AroCell
€0.03
0
+€0+0% Today
Statistics
Day High
0.03
Day Low
0.02
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
12MayConfirmed
Q1 2020
Q2 2020
Q3 2020
Q1 2021
-0.08
-0.08
-0.08
-0.08
Expected EPS
N/A
Actual EPS
-0.0803
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 80R.F. It's not an investment recommendation.
About
AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Uppsala, Sweden.
Show more...
CEO
Prof. Gunnar Steineck Ph.D.
Employees
20
Country
SE
ISIN
SE0003883990
WKN
000A12CNW